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Background
Juvenile Arthritis Disease Activity Score (JADAS) is a
recently developed composite tool for scoring disease
activity in juvenile idiopathic arthritis (JIA). JADAS con-
sists of four items; the joint count, the physician and the
patient’s/parent’s global assessment and the erythrocyte
sedimentation rate (ESR) as an inflammatory marker. C-
reactive protein (CRP) has been suggested as an alterna-
tive inflammatory marker [1].
Aim
The aim of the study was to validate and compare the
CRP versus the ESR as an inflammatory marker and to
validate in JADAS in a Nordic population-based setting.
Methods
We included newly diagnosed cases of JIA from defined
geographical areas of Denmark, Finland, Sweden and
Norway with disease onset in 1997 to 2000 followed
longitudinally during the first eight years of the disease.
The construct validity, predictive and discriminative
ability, and sensitivity to change of JADAS were assessed
by comparing with other measures of disease activity
and outcome.
Results
At the first study visit with all JADAS items available in
389 children, the correlation between JADAS27-CRP
and JADAS27-ESR was 0.99. Children with higher
JADAS scores had increased risk of concomitant pain,
physical disability and use of disease modifying anti-
rheumatic drugs (DMARD). Higher JADAS score at the
first study visit also significantly predicted physical dis-
ability, damage, and DMARD during the disease course
and no remission off medication at the final study visit.
Median JADAS of the oligoarticular persistent category
differed significantly compared to median score of all
other categories (JADAS27-CRP; p=0.0002 and
JADAS27-ESR; p=0.0004). Sensitivity to change was
demonstrated as change in JADAS score compared to
the American College of Rheumatology paediatric mea-
sures of improvement criteria, showed mostly excellent
classification ability.
Conclusions
The JADAS-CRP and JADAS-ESR correlate closely,
show similar test characteristics, and are demonstrated
to be feasible and valid tools to assess disease activity in
all categories of JIA.
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